...
首页> 外文期刊>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association >Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experience.
【24h】

Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experience.

机译:筛查血管患者的肾脏疾病:筛查隐匿性肾病(SCORED)经验。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: SCreening for Occult REnal Disease (SCORED) is a novel screening guideline recently developed to identify individuals with a high likelihood of having prevalent chronic kidney disease (CKD). This simple scoring system, developed from general US representative samples and independently validated, was shown to outperform current clinical practice guidelines. Recently, CKD screening in individuals with cardiovascular disease (CVD) has been emphasized. We therefore evaluated the SCORED model in CVD patients in order to better understand the implications of CKD screening in this population. METHODS: Two clinical trials that enrolled patients with heart attack (N = 2481) or stroke (N = 3680) were combined to create our sample. The performance of the SCORED guideline was evaluated by standard diagnostic measures. Correlations among various risk scores and their predictive abilities for recurrent CVD were ascertained. RESULTS: For heart attack and stroke patients, respectively, the SCORED guideline yielded sensitivity of 94 and 97%, specificity of 27 and 11%, positive predictive value of 32 and 30%, negative predictive value of 93 and 89%, with AUC of 0.75 and 0.68. SCORED was strongly correlated with other risk scores and exhibited a similar performance in the prediction of recurrent CVD. CONCLUSIONS: The higher risk of CKD in CVD patients with high SCORED values is demonstrated. This simple education and screening tool may help promote awareness of CKD in CVD patients, in addition to general populations, and assess the CKD risk and its relationship with recurrent CVD.
机译:背景:隐匿性肾脏疾病筛查(SCORED)是最近开发的一种新的筛查指南,用于鉴定极有可能患上慢性肾脏病(CKD)的个体。这个简单的评分系统是根据美国的代表性样品开发并经过独立验证的,其性能优于目前的临床实践指南。近来,已经强调了在患有心血管疾病(CVD)的个体中进行CKD筛查。因此,我们评估了CVD患者的SCORED模型,以更好地了解CKD筛查在该人群中的意义。方法:两项纳入心脏病发作(N = 2481)或中风(N = 3680)患者的临床试验被合并以创建我们的样本。 SCORED指南的性能通过标准诊断措施进行了评估。确定了各种风险评分之间的相关性及其对复发性CVD的预测能力。结果:对于心脏病发作和中风患者,SCORED指南分别产生94和97%的敏感性,27和11%的特异性,32和30%的阳性预测值,93和89%的阴性预测值,AUC为0.75和0.68。 SCORED与其他风险评分密切相关,在预测复发性CVD中表现出相似的表现。结论:SCORED值高的CVD患者发生CKD的风险较高。除了一般人群之外,这种简单的教育和筛查工具还可以帮助提高CVD患者对CKD的认识,并评估CKD风险及其与复发性CVD的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号